March 5, 2018 / 7:22 AM / 5 months ago

BRIEF-Astrazeneca Says EMA Accepts Submission For Forxiga In Adults With Type-1 Diabetes

Reuters Staff

1 Min Read

March 5 (Reuters) - Astrazeneca Plc:

* ‍EUROPEAN MEDICINES AGENCY ACCEPTS REGULATORY SUBMISSION FOR FORXIGA IN ADULTS WITH TYPE-1 DIABETES

* ‍SUBMISSION ACCEPTANCE IS BASED ON PHASE III DATA FROM DEPICT CLINICAL PROGRAMME FOR FORXIGA IN T1D Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

BRIEF-Astrazeneca Says EMA Accepts Submission For Forxiga In Adults With Type-1 Diabetes​

BRIEF-Astrazeneca Says EMA Accepts Submission For Forxiga In Adults With Type-1 Diabetes